Elevated Lipoprotein(a) With Zero Coronary Artery Calcium: A Silent Threat or a Clinical Paradox?
作者信息
Rodriguez Lozano Patricia F, Hosadurg Nisha
机构信息
Department of Medicine, Cardiovascular Division (P.F.R.L., N.H.), University of Virginia Health, Charlottesville.
Department of Radiology and Medical Imaging (P.F.R.L.), University of Virginia Health, Charlottesville.
出版信息
Circ Cardiovasc Imaging. 2024 Jul;17(7):e017136. doi: 10.1161/CIRCIMAGING.124.017136. Epub 2024 Jul 16.
Abstract
摘要
相似文献
1
Elevated Lipoprotein(a) With Zero Coronary Artery Calcium: A Silent Threat or a Clinical Paradox?脂蛋白(a)升高但冠状动脉钙化积分零：是隐匿威胁还是临床悖论？
Circ Cardiovasc Imaging. 2024 Jul;17(7):e017136. doi: 10.1161/CIRCIMAGING.124.017136. Epub 2024 Jul 16.
2
Lipoprotein(a) and Progression of Coronary Artery Calcification in a Pooled U.S. Cohort.
JACC Cardiovasc Imaging. 2024 Oct;17(10):1265-1267. doi: 10.1016/j.jcmg.2024.05.023. Epub 2024 Aug 7.
3
Lipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida.脂蛋白(a)与无症状个体的冠状动脉斑块：美国佛罗里达州南浸信会健康中心的迈阿密心脏研究。
Circ Cardiovasc Imaging. 2024 Jul;17(7):e016152. doi: 10.1161/CIRCIMAGING.123.016152. Epub 2024 Jul 16.
4
Elevated lipoprotein(a) is not linked to coronary artery calcification incidence or progression.脂蛋白(a)升高与冠状动脉钙化的发生率或进展无关。
Eur J Prev Cardiol. 2025 Apr 3. doi: 10.1093/eurjpc/zwaf088.
5
Coronary artery calcium-guided prevention: The time is now!冠状动脉钙化引导的预防：时机已至！
J Cardiovasc Comput Tomogr. 2017 Nov;11(6):421-422. doi: 10.1016/j.jcct.2017.10.002. Epub 2017 Oct 7.
6
Partially calcified plaque mimicking the "napkin-ring sign" on coronary CT angiography.在冠状动脉CT血管造影上表现为类似“餐巾环征”的部分钙化斑块。
J Cardiovasc Comput Tomogr. 2017 May-Jun;11(3):244. doi: 10.1016/j.jcct.2017.01.005. Epub 2017 Jan 22.
7
Primary prevention of coronary artery disease: let's start with calcium score.冠状动脉疾病的一级预防：让我们从钙化积分开始。
J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e103-e106. doi: 10.2459/JCM.0000000000000563.
8
Coronary Artery Calcium Density and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis.冠状动脉钙化密度与心血管事件风险：一项系统评价和荟萃分析。
JACC Cardiovasc Imaging. 2025 Mar;18(3):294-304. doi: 10.1016/j.jcmg.2024.07.024. Epub 2024 Sep 4.
9
Lipoprotein(a) is an important factor to determine coronary artery plaque morphology in patients with acute myocardial infarction.脂蛋白(a)是决定急性心肌梗死患者冠状动脉斑块形态的重要因素。
Coron Artery Dis. 2013 Aug;24(5):381-5. doi: 10.1097/MCA.0b013e3283622329.
10
The role of chest pain symptoms in predicting coronary artery disease severity and MACE events in patients with zero CAC: a study from a large CCTA cohort.胸痛症状在预测零钙化积分患者的冠状动脉疾病严重程度及主要不良心血管事件中的作用：一项来自大型CT血管造影队列研究
Int J Cardiovasc Imaging. 2025 Jul 15. doi: 10.1007/s10554-025-03454-2.
本文引用的文献
1
Lipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida.脂蛋白(a)与无症状个体的冠状动脉斑块：美国佛罗里达州南浸信会健康中心的迈阿密心脏研究。
Circ Cardiovasc Imaging. 2024 Jul;17(7):e016152. doi: 10.1161/CIRCIMAGING.123.016152. Epub 2024 Jul 16.
2
Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.脂蛋白(a)与多民族队列前瞻性研究的长期心血管风险。
J Am Coll Cardiol. 2024 Apr 23;83(16):1511-1525. doi: 10.1016/j.jacc.2024.02.031.
3
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.2019 年 NLA 科学声明中脂蛋白(a)在临床实践中应用的重点更新。
J Clin Lipidol. 2024 May-Jun;18(3):e308-e319. doi: 10.1016/j.jacl.2024.03.001. Epub 2024 Apr 1.
4
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study.脂蛋白(a)水平的性别差异及其与年龄相关的发病和死亡风险：哥本哈根普通人群研究。
Atherosclerosis. 2022 Aug;355:76-82. doi: 10.1016/j.atherosclerosis.2022.06.1023. Epub 2022 Jun 27.
5
Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study.脂蛋白(a)与心脏 CT 扫描下的亚临床血管及瓣膜钙化：社区动脉粥样硬化风险研究。
J Am Heart Assoc. 2022 Jun 7;11(11):e024870. doi: 10.1161/JAHA.121.024870. Epub 2022 Jun 3.
6
Lipoprotein(a) and ethnicities.脂蛋白(a)与种族。
Atherosclerosis. 2022 May;349:42-52. doi: 10.1016/j.atherosclerosis.2022.04.005.
7
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk.载脂蛋白(a)与冠状动脉钙化独立相关，与动脉粥样硬化性心血管风险相关。
J Am Coll Cardiol. 2022 Mar 1;79(8):757-768. doi: 10.1016/j.jacc.2021.11.058.
8
Association of Lipoprotein(a) With Atherosclerotic Plaque Progression.载脂蛋白(a)与动脉粥样硬化斑块进展的关系。
J Am Coll Cardiol. 2022 Jan 25;79(3):223-233. doi: 10.1016/j.jacc.2021.10.044.
9
Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals.脂蛋白(a)与无症状个体亚临床冠状动脉粥样硬化。
Atherosclerosis. 2022 May;349:190-195. doi: 10.1016/j.atherosclerosis.2021.09.027. Epub 2021 Sep 28.
10
Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank.脂蛋白(a)（Lipoprotein[a]）浓度与动脉粥样硬化性心血管疾病的发生：来自大型国家生物库的新见解。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):465-474. doi: 10.1161/ATVBAHA.120.315291. Epub 2020 Oct 29.
Zotero 插件